Annovis Bio ANVS
NYSE ANVS
$1.01 +0.03 (+3.24%)
As of: Oct 21, 2026 · 10:49 AM EDT

Annovis Bio (ANVS) Non-Current Debt (2019)

Updated

Analysis

Annovis Bio (ANVS) Non-Current Debt (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 62.48 Bn
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 60.50 Bn
10 Annovis Bio 37.89 Mn -29.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 530,000.00
API Access

Annovis Bio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ANVS&period=max&api_key=YOUR_API_KEY